- OREXIN RECEPTOR ANTAGONISTS
-
The disclosures herein relate to novel compounds of formula wherein W, X and Y1, Y2, Y3 and Y4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.
- -
-
Page/Page column 96
(2014/01/18)
-
- Self-assembly of organocatalysts: Fine-tuning organocatalytic reactions
-
(Chemical Equation Presented) A cat. with two tales: Hydrogen-bonding interactions between achiral pyridinone additives and unselective chiral proline-derived organocatalysts (see picture) result in highly effective catalysts for the Michael addition of n
- Clarke, Matthew L.,Fuentes, Jose A.
-
p. 930 - 933
(2008/02/01)
-